The earnings call showcased Cigna's strong financial results and strategic initiatives, particularly in the Evernorth segment and innovative healthcare solutions. However, the company faces challenges with elevated medical costs and pressures in the individual exchange business. Overall, the positive highlights outweigh the lowlights.

Company Guidance -

Q3 2025

During the second quarter of 2025, The Cigna Group reported total revenue of $67.2 billion and adjusted earnings per share (EPS) of $7.20. The company reaffirmed its full-year guidance, anticipating at least $29.60 in adjusted EPS. This achievement reflects a strong performance across its platforms, with Evernorth contributing significantly with $57.8 billion in revenue, showing growth particularly in its Specialty and Care Services division. Meanwhile, Cigna Healthcare delivered $10.8 billion in revenue with a medical care ratio of 83.2%. The company managed after-tax special item charges of $171 million, or $0.64 per share. Cigna also highlighted its strategic focus on innovation and partnerships, introducing new AI-powered solutions and negotiating multiyear contracts, such as with Prime Therapeutics. The overall guidance included potential impacts from share repurchases and anticipated dividends, while maintaining a dynamic approach in response to the evolving regulatory and technological landscape.

Strong Financial Performance

Cigna reported a total revenue of $67.2 billion and adjusted earnings per share of $7.20 for Q2 2025. The company reaffirmed its outlook for full-year 2025 with expected adjusted earnings per share of at least $29.60.

Evernorth Segment Growth

Evernorth's Specialty and Care Services saw a 13% revenue increase to $25.9 billion, with normalized pretax adjusted earnings growth of 12% year-over-year. Pharmacy Benefit Services also demonstrated solid growth with pretax adjusted earnings of $833 million.

Cigna Healthcare Performance

Cigna Healthcare reported a medical care ratio of 83.2%, in line with expectations, and continued to grow in the U.S. employer segment, particularly in the Select segment.

AI-Powered Virtual Assistant Launch

Cigna Healthcare introduced a new AI-powered virtual assistant to enhance customer experience in areas such as checking benefits and finding care.

New GLP-1 Benefit Option

Evernorth launched a benefit option to save patients money on GLP-1 weight loss prescriptions, with out-of-pocket costs limited to $200 per month.

Cigna (CI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	7.66 / -	7.51	―	―	―
Jul 31, 2025	2025 (Q2)	7.16 / 7.20	6.72	7.14% (+0.48)	―
May 02, 2025	2025 (Q1)	6.35 / 6.74	6.47	4.17% (+0.27)	―
Jan 30, 2025	2024 (Q4)	7.83 / 6.64	6.79	-2.21% (-0.15)
Oct 31, 2024	2024 (Q3)	7.23 / 7.51	6.77	10.93% (+0.74)
Aug 01, 2024	2024 (Q2)	6.43 / 6.72	6.13	9.62% (+0.59)
May 02, 2024	2024 (Q1)	6.22 / 6.47	5.41	19.59% (+1.06)
Feb 02, 2024	2023 (Q4)	6.54 / 6.79	4.96	36.90% (+1.83)
Nov 02, 2023	2023 (Q3)	6.68 / 6.77	6.04	12.09% (+0.73)
Aug 03, 2023	2023 (Q2)	6.03 / 6.13	6.22	-1.45% (-0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$297.86	$267.38	-10.23%
May 02, 2025	$333.57	$333.14	-0.13%
Jan 30, 2025	$300.38	$280.25	-6.70%
Oct 31, 2024	$308.57	$310.46	+0.61%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.